Pancreatitis was rare in the SURPASS and SURMOUNT clinical trials involving over 6,000 participants, with incidence rates comparable to control groups and not significantly elevated compared to placebo
Is Frontier Peptide Labs Retatrutide for research use only
By restoring gut integrity and reducing GI inflammation, BPC-157 effectively shuts off the tap of these pro-inflammatory signals at their source
Visual and statistical assessments using funnel plots and Beggs and Eggers tests were performed regarding the risk of publication bias ( 3 Results 3.1 Study selection A total of 5,387 records were initially identified806 from PubMed, 1,531 from Embase, 1,175 from Web of Science, and 2,213 from Scopusand after removing 2,284 duplicates, 3,003 studies were screened based on title and abstract